Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory BoardGlobeNewsWire • 05/08/23
Caribou Biosciences Presents New Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the 2023 AACR Annual MeetingGlobeNewsWire • 04/17/23
CRBU ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2023 in the Class Action Filed on Behalf of Caribou Biosciences, Inc. ShareholdersPRNewsWire • 04/11/23
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Caribou Investors of a Lead Plaintiff Deadline of April 11, 2023PRNewsWire • 04/10/23
CRBU IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - CRBUPRNewsWire • 04/06/23
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Caribou Biosciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 11, 2023 - (NASDAQ: CRBU)PRNewsWire • 04/05/23
Caribou Biosciences Announces FDA Granted Fast Track Designation to CB-011, an Allogeneic CAR-T Cell Therapy for Relapsed or Refractory Multiple MyelomaGlobeNewsWire • 04/04/23
CRBU SHAREHOLDER ALERT: Jakubowitz Law Reminds Caribou Shareholders of a Lead Plaintiff Deadline of April 11, 2023PRNewsWire • 03/31/23
CRBU LAWSUIT ALERT: Levi & Korsinsky Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 03/30/23
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUPRNewsWire • 03/24/23
CARIBOU BIOSCIENCES, INC. (NASDAQ: CRBU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Caribou Biosciences, Inc. (NASDAQ: CRBU)PRNewsWire • 03/22/23
ROSEN, A LEADING NATIONAL FIRM, Encourages Caribou Biosciences, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CRBUPRNewsWire • 03/16/23
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/10/23
ROSEN, A LONGSTANDING LAW FIRM, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRBUPRNewsWire • 03/09/23
Caribou Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 03/09/23
Caribou Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceGlobeNewsWire • 03/08/23
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUPRNewsWire • 02/28/23
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - CRBUPRNewsWire • 02/23/23
Caribou Biosciences, Inc. (CRBU) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Caribou Biosciences, Inc.Business Wire • 02/22/23
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUPRNewsWire • 02/21/23
Bronstein, Gewirtz & Grossman, LLC Notifies Caribou Biosciences, Inc. (CRBU) Investors of Class Action and to Actively ParticipatePRNewsWire • 02/20/23
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRBUNewsfile Corp • 02/18/23
Caribou Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 11, 2023 to Discuss Your Rights - CRBUNewsfile Corp • 02/17/23
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Caribou Biosciences, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/17/23
